JSPR logo

Jasper Therapeutics, Inc.

JSPR
Healthcare|Biotechnology|US
$16.86
+2.78 (+19.78%)
DCF Value
$34.77
Tangible Book / Share
$1.48
Cash / Share
$7.65
Next Earnings Report
Mar 9, 2027
EPS est. -$0.30
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Oct 14, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (7)

Dec 2026
Est. completion
NAObsessive-Compulsive Disorder
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
NCT05467683n=600
Jan 2027
Est. completion
Glioblastoma
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT06283927n=464
Jan 2027
Est. completion
Glioblastoma
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
NCT06118723n=784
Jan 2028
Est. completion
Glioblastoma
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
NCT06146738n=1,015
Jan 2028
Est. completion
Glioblastoma
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
NCT06146725n=564
Mar 2029
Est. completion
P3Nicotine Dependence
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
NCT06053567n=360
Jun 2029
Est. completion
HFrEF - Heart Failure With Reduced Ejection Fraction
Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)
NCT07702760n=1,500

Recent Press Releases

Jasper Therapeutics Announces 1-for-30 Reverse Stock Split
Nov 4, 2026 · GlobeNewsWire
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
Oct 15, 2026 · GlobeNewsWire
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
Oct 7, 2026 · GlobeNewsWire
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
Sep 15, 2026 · GlobeNewsWire
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 9, 2026 · GlobeNewsWire
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 14, 2026 · GlobeNewsWire

SEC Filings (84)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 28, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 23, 2026SC TO-I/ATender offerDocumentIndex
Oct 19, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 15, 20268-KMaterial eventDocumentIndex
Oct 14, 2026S-3Shelf registrationDocumentIndex
Oct 9, 2026PRE 14AProxy / shareholder voteDocumentIndex
Oct 7, 20268-KMaterial eventDocumentIndex
Oct 7, 2026SC TO-ITender offerDocumentIndex
Oct 5, 20268-KMaterial eventDocumentIndex
Oct 5, 20268-K/AMaterial eventDocumentIndex
Oct 1, 20268-K/AMaterial eventDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Sep 24, 202625-NSEDocumentIndex
Sep 4, 2026DEF 14AProxy / shareholder voteDocumentIndex
Aug 26, 20268-KMaterial eventDocumentIndex
Aug 24, 2026PRE 14AProxy / shareholder voteDocumentIndex
Aug 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 5, 2026DDocumentIndex
Aug 3, 20268-KMaterial eventDocumentIndex
Jul 31, 20268-KMaterial eventDocumentIndex
Jul 20, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 17, 20268-KMaterial eventDocumentIndex
Jul 16, 20268-KMaterial eventDocumentIndex
Jul 10, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 15, 2026ARSAnnual report to holdersDocumentIndex
Jun 15, 2026DEFA14AProxy / shareholder voteDocumentIndex
Jun 15, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jun 9, 20268-KMaterial eventDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 30, 202610-K/AAnnual reportDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex